A higher dose of the experimental pill for sickle cell disease showed more promise, Fulcrum said at the American Society of ...
Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...
A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...
At the end of a tense year for science, the American Society of Hematology heard promising data on acute myeloid leukemia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback